Investment Ratings
As per analysts rating in the last 6 months, the recommendation is to HOLD Vimta Labs
-
Master Rating:
-
Vimta Labs has an operating revenue of Rs. 229.47 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 14% is healthy, ROE of 11% is good. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 42% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 8% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 75 which is a FAIR score but needs to improve its earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 148 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Vimta Labs Ltd Forecast
Price Estimates
Eps And Sales Estimates
Vimta Labs Ltd Synopsis
NSE-Medical-Research Eqp/Svc
Vimta Labs Ltd. belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 209.05 Cr. and Equity Capital is Rs. 4.42 Cr. for the Year ended 31/03/2021. Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977.-
Market Cap
INR 829.16 Cr
-
Sales
INR 253.38 Cr
-
Shares in Float
1.39 Cr
-
No of Funds
3 K
-
Yield
0.53%
-
Book Value
4.28
-
U/D Vol Ratio
1.8
-
LTDebt/Equity
7%
-
Alpha
0.34
-
Beta
0.78
| Owner Name | Jun-21 | Mar-21 | Dec-20 |
|---|---|---|---|
| Promoters | 37.46% | 37.46% | 37.46% |
| Mutual Funds | 0% | 0% | 0% |
| Foreign Portfolio Investors | 0% | 0% | 0% |
| Individual Investors | 29.45% | 29.08% | 28.82% |
| Others | 33.09% | 33.46% | 33.72% |
| Name | Designation |
|---|---|
| Dr. Sivalinga Prasad Vasireddi | Non Executive Chairman |
| Mr. Harita Vasireddi | Managing Director |
| Mr. Harriman Vungal | Executive Director - Operations |
| Mr. Satya Sreenivas Neerukonda | Executive Director |
| Mrs. Prameela Rani Yalamanchili | Independent Director |
| Dr. Yadagiri R Pendri | Independent Director |
| Mr. Sanjay Dave | Independent Director |
| Mr. Purnachandra Rao Gutta | Independent Director |
Vimta Labs Ltd Financials
- Quarterly P&L
- Annual P&L
- Cash Flow
- Balance Sheet
- Ratios
| INDICATOR | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 74.696 | 61.005 | 59.493 | 58.187 | 58.803 |
| Operating Expenses Qtr Cr | 55.068 | 44.318 | 42.833 | 41.609 | 43.008 |
| Operating Profit Qtr Cr | 19.628 | 16.687 | 16.66 | 16.578 | 15.795 |
| Depreciation Qtr Cr | 5.48 | 5.493 | 5.787 | 5.731 | 5.78 |
| Interest Qtr Cr | 0.242 | 0.432 | 0.678 | 0.581 | 0.317 |
| Tax Qtr Cr | 3.299 | 2.838 | 2.686 | 2.558 | 2.359 |
| Net Profit Qtr Cr | 9.513 | 8.105 | 7.747 | 8.012 | 7.376 |
| INDICATOR | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
| Total Revenue Annual Cr | 209.861 | 183.692 | 214.568 | 184.648 | 154.789 |
| Operating Expenses Annual Cr | 156.36 | 150.659 | 155.097 | 138.184 | 126.537 |
| Operating Profit Annual in Cr | 52.691 | 30.015 | 57.544 | 45.267 | 27.311 |
| Depreciation Cr | 22.937 | 20.922 | 19.723 | 15.7 | 9.63 |
| Interest Annual Cr | 2.167 | 3.765 | 4.607 | 5.2 | 2.087 |
| Tax Annual Cr | 7.137 | 1.419 | 9.83 | 9.131 | 5.943 |
| Net Profit Annual Cr | 21.26 | 6.927 | 25.311 | 16.433 | 10.592 |
| INDICATOR | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
| Cash from Operating Activity Annual Cr | 36.969 | 24.365 | 39.146 | 33.421 | 23.92 |
| Cash from Investing Activity Annual Cr | -31.872 | -20.092 | -15.65 | -23.766 | -39.412 |
| Cash from Financing Annual Activity Cr | -4.57 | -1.457 | -22.824 | -8.285 | 13.236 |
| Net Cash Flow Annual Cr | 0.527 | 2.816 | 0.672 | 1.37 | -2.256 |
| INDICATOR | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
| Total ShareHolders Funds Annual Cr | 194.319 | 172.959 | 171.552 | 152.053 | 136.148 |
| Fixed Assets Annual Cr | 145.03 | 132.905 | 138.904 | 140.39 | 141.216 |
| Total Non Current Assets Annual Cr | 162.639 | 148.897 | 145.11 | 148.692 | 151.82 |
| Total Current Assets Annual Cr | 110.435 | 95.635 | 92.317 | 83.563 | 69.826 |
| Total Assets Annual Cr | 273.074 | 244.532 | 237.427 | 232.255 | 221.646 |
| INDICATOR | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
| Book Value Per Share Annual Rs | 87.8872 | 78.2264 | 77.5902 | 68.771 | 61.5774 |
| ROE Annual % | 10.94 | 4 | 14.75 | 10.8 | 7.77 |
| ROCE Annual % | 13.87 | 6.46 | 20.47 | 16.86 | 11.48 |
| Total Debt to Total Equity Annual | - | - | - | - | - |
| EBDIT Annual Margin % | 25.59 | 18.28 | 27.96 | 25.32 | 18.36 |
Vimta Labs Ltd Technicals
EMA & SMA
CURRENT PRICE
375.65 
(-0.24)
-
- Bullish Moving Averages 16
- Bearish Moving Averages 0
EMA
-
20 Day
359.87
-
50 Day
336.99
-
100 Day
310.96
-
200 Day
263.57
Vimta Labs Ltd Resistance and support
376.19 PIVOT
-
First Resistance
382.37
-
Second Resistance
388.19
-
Third Resistance
394.37
-
First Support
370.37
-
Second Support
364.19
-
Third Support
358.37
-
RSI
59.74
-
MFI
77.84
-
MACD
12.75
-
MACD signal line
13.33
Vimta Labs Ltd Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 72,490 | 4,041,318 | 55.75% |
| Week | 211,950 | 9,406,341 | 44.38% |
| 1 Month | 192,317 | 8,502,339 | 44.21% |
| 6 Month | 250,102 | 9,814,013 | 39.24% |
Vimta Labs Ltd Price change analysis
35.1
Over 1 month
Low High 340.6 405.25
83.15
Over 3 month
Low High 269.6 405.25
153.3
Over 6 months
Low High 221 405.25
227.95
Over Year
Low High 144 405.25Similar Stocks
| Company Name | 52 Week () |
Market Price () | Volume |
|---|---|---|---|
| Mangalam Timber Products Ltd | 20.05 | 15.15 (-4.72%) | 250 |
| Oriental Trimex Ltd | 13.25 | 9.33 (-0.85%) | 5801 |
| Antony Waste Handling Cell Ltd | 492.75 | 291.90 (-0.83%) | 17495 |
| Archidply Decor Ltd | 55.95 | 49.60 (-1.78%) | 603 |
News
VIMTA LABS LTD.-$ - 524394 - Compliances-Reg. 39 (3) - Detai
Intimation regarding receipt of Information for loss of share certificate Read More
VIMTA LABS LTD.-$ - 524394 - Disclosure Of Related Party Tra
Related Party Transactions on consolidated basis for the half year ended September 30, 2021 Read More
VIMTA LABS LTD.-$ - 524394 - Compliances-Reg. 39 (3) - Detai
Intimation regarding receipt of Information for loss of share certificate. Read More
Hot Stocks | Here is why you should buy Vimta Labs and sell
Going ahead, since the market is a bit oversold, we may see some relief move in between; but traders should not get carried away by such reb Read More
Vimta Labs Ltd - 524394 - Announcement under Regulation 30 (
Transcript of the Q2-2022 earnings/investor call held on 25th October 2021. Read MoreBlogs